The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
RNA Demethylase ALKBH5 Selectively Promotes Tumorigenesis and Cancer Stem Cell Self-Renewal in Acute Myeloid Leukemia
Open accessAbstract
SUMMARY N6-methyladenosine (m6A), the most abundant internal modification in mRNA, has been implicated in tumorigenesis. As an m6A demethylase, ALKBH5 has been shown to promote the development of breast cancer and brain tumors. However, in acute myeloid leukemia (AML), ALKBH5 was reported to be frequently deleted, implying a tumor-suppressor role. Here, we show that ALKBH5 deletion is rare in human AML; instead, ALKBH5 is aberrantly overexpressed in AML. Moreover, its increased expression correlates with poor prognosis in AML patients. We demonstrate that ALKBH5 is required for the development and maintenance of AML and self-renewal of leukemia stem/initiating cells (LSCs/LICs), but not essential for normal hematopoiesis. Mechanistically, ALKBH5 exerts tumor-promoting effects in AML by post-transcriptional regulation of its critical targets such as TACC3, a prognosis-associated oncogene in various cancers. Collectively, our findings reveal essential functions of ALKBH5 in leukemogenesis and LSC/LIC self-renewal/maintenance, and highlight the therapeutic potential of targeting the ALKBH5/m6A axis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Genome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133
Döhner, H., Estey, E., Grimwade, D., Amadori, S., Appelbaum, F. R., Büchner, T., Dombret, H., Ebert, B. L., Fenaux, P., Larson, R. A., et al. (2017) · Blood · doi:10.1182/blood-2016-08-733196 · Cited by 5,775
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
The Cancer Genome Atlas Research Network (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301689 · Cited by 5,078
Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq
Dominissini, D., Moshitch-Moshkovitz, S., Schwartz, S., Salmon-Divon, M., Ungar, L., Osenberg, S., Cesarkas, K., Jacob-Hirsch, J., Amariglio, N., Kupiec, M., et al. (2012) · Nature · doi:10.1038/nature11112 · Cited by 4,884
N6-methyladenosine-dependent regulation of messenger RNA stability
Wang, X., Lu, Z., Gomez, A., Hon, G. C., Yue, Y., Han, D., Fu, Y., Parisien, M., Dai, Q., Jia, G., et al. (2014) · Nature · doi:10.1038/nature12730 · Cited by 4,558
Self-citationFunctional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs
Rinn, J. L., Kertesz, M., Wang, J. K., Squazzo, S. L., Xu, X., Brugmann, S. A., Goodnough, L. H., Helms, J. A., Farnham, P. J., Segal, E., et al. (2007) · Cell · doi:10.1016/j.cell.2007.05.022 · Cited by 4,244
N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO
Jia, G., Fu, Y., Zhao, X., Dai, Q., Zheng, G., Yang, Y., Yi, C., Lindahl, T., Pan, T., Yang, Y.-G., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.687 · Cited by 4,106
Self-citationALKBH5 Is a Mammalian RNA Demethylase that Impacts RNA Metabolism and Mouse Fertility
Zheng, G., Dahl, J. A., Niu, Y., Fedorcsak, P., Huang, C.-M., Li, C. J., Vågbø, C. B., Shi, Y., Wang, W.-L., Song, S.-H., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2012.10.015 · Cited by 3,550
Self-citationN6-methyladenosine Modulates Messenger RNA Translation Efficiency
Wang, X., Zhao, B. S., Roundtree, I. A., Lu, Z., Han, D., Ma, H., Weng, X., Chen, K., Shi, H., & He, C. (2015) · Cell · doi:10.1016/j.cell.2015.05.014 · Cited by 3,483
Self-citationA METTL3–METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation
Liu, J., Yue, Y., Han, D., Wang, X., Fu, Y., Zhang, L., Jia, G., Yu, M., Lu, Z., Deng, X., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1432 · Cited by 3,433
Self-citationRecognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation
Huang, H., Weng, H., Sun, W., Qin, X., Shi, H., Wu, H., Zhao, B. S., Mesquita, A., Liu, C., Yuan, C. L., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0045-z · Cited by 2,997
Self-citationBatlle, E., & Clevers, H. (2017) · Nature Medicine · doi:10.1038/nm.4409 · Cited by 2,769
Sakamoto, K. M., Kim, K. B., Kumagai, A., Mercurio, F., Crews, C. M., & Deshaies, R. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.141230798 · Cited by 2,609
Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase
Ping, X.-L., Sun, B.-F., Wang, L., Xiao, W., Yang, X., Wang, W.-J., Adhikari, S., Shi, Y., Lv, Y., Chen, Y.-S., et al. (2014) · Cell Research · doi:10.1038/cr.2014.3 · Cited by 2,375
Self-citationHu, Y., & Smyth, G. K. (2009) · Journal of Immunological Methods · doi:10.1016/j.jim.2009.06.008 · Cited by 2,083
Self-citationNuclear m6A Reader YTHDC1 Regulates mRNA Splicing
Xiao, W., Adhikari, S., Dahal, U., Chen, Y.-S., Hao, Y.-J., Sun, B.-F., Sun, H.-Y., Li, A., Ping, X.-L., Lai, W.-Y., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.01.012 · Cited by 2,054
Self-citationN6-methyladenosine-dependent RNA structural switches regulate RNA–protein interactions
Liu, N., Dai, Q., Zheng, G., He, C., Parisien, M., & Pan, T. (2015) · Nature · doi:10.1038/nature14234 · Cited by 1,988
Self-citationDNMT3A Mutations in Acute Myeloid Leukemia
Ley, T. J., Ding, L., Walter, M. J., McLellan, M. D., Lamprecht, T., Larson, D. E., Kandoth, C., Payton, J. E., Baty, J., Welch, J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005143 · Cited by 1,983
5′ UTR m6A Promotes Cap-Independent Translation
Meyer, K. D., Patil, D. P., Zhou, J., Zinoviev, A., Skabkin, M. A., Elemento, O., Pestova, T. V., Qian, S.-B., & Jaffrey, S. R. (2015) · Cell · doi:10.1016/j.cell.2015.10.012 · Cited by 1,806
Mutation in TET2 in Myeloid Cancers
Delhommeau, F., Dupont, S., Valle, V. D., James, C., Trannoy, S., Massé, A., Kosmider, O., Le Couedic, J.-P., Robert, F., Alberdi, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810069 · Cited by 1,776
Lentivirus-delivered stable gene silencing by RNAi in primary cells
STEWART, S. A., DYKXHOORN, D. M., PALLISER, D., MIZUNO, H., YU, E. Y., AN, D. S., SABATINI, D. M., CHEN, I. S. Y., HAHN, W. C., SHARP, P. A., et al. (2003) · RNA · doi:10.1261/rna.2192803 · Cited by 1,582
Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9
Krivtsov, A. V., Twomey, D., Feng, Z., Stubbs, M. C., Wang, Y., Faber, J., Levine, J. E., Wang, J., Hahn, W. C., Gilliland, D. G., et al. (2006) · Nature · doi:10.1038/nature04980 · Cited by 1,513
FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N 6 -Methyladenosine RNA Demethylase
Li, Z., Weng, H., Su, R., Weng, X., Zuo, Z., Li, C., Huang, H., Nachtergaele, S., Dong, L., Hu, C., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2016.11.017 · Cited by 1,508
Self-citationZhang, S., Zhao, B. S., Zhou, A., Lin, K., Zheng, S., Lu, Z., Chen, Y., Sulman, E. P., Xie, K., Bögler, O., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.02.013 · Cited by 1,459
Self-citationN6-methyladenosine modification destabilizes developmental regulators in embryonic stem cells
Wang, Y., Li, Y., Toth, J. I., Petroski, M. D., Zhang, Z., & Zhao, J. C. (2014) · Nature Cell Biology · doi:10.1038/ncb2902 · Cited by 1,290
MLL translocations, histone modifications and leukaemia stem-cell development
Krivtsov, A. V., & Armstrong, S. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2253 · Cited by 1,249
Vu, L. P., Pickering, B. F., Cheng, Y., Zaccara, S., Nguyen, D., Minuesa, G., Chou, T., Chow, A., Saletore, Y., MacKay, M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4416 · Cited by 1,237
m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer
Huang, H., Weng, H., & Chen, J. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.02.004 · Cited by 1,226
Self-citationR-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling
Su, R., Dong, L., Li, C., Nachtergaele, S., Wunderlich, M., Qing, Y., Deng, X., Wang, Y., Weng, X., Hu, C., et al. (2018) · Cell · doi:10.1016/j.cell.2017.11.031 · Cited by 1,137
Self-citationPromoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control
Barbieri, I., Tzelepis, K., Pandolfini, L., Shi, J., Millán-Zambrano, G., Robson, S. C., Aspris, D., Migliori, V., Bannister, A. J., Han, N., et al. (2017) · Nature · doi:10.1038/nature24678 · Cited by 1,086
Zhang, C., Samanta, D., Lu, H., Bullen, J. W., Zhang, H., Chen, I., He, X., & Semenza, G. L. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602883113 · Cited by 971
Weng, H., Huang, H., Wu, H., Qin, X., Zhao, B. S., Dong, L., Shi, H., Skibbe, J., Shen, C., Hu, C., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2017.11.016 · Cited by 968
Self-citationSmall-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia
Huang, Y., Su, R., Sheng, Y., Dong, L., Dong, Z., Xu, H., Ni, T., Zhang, Z. S., Zhang, T., Li, C., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.03.006 · Cited by 877
Self-citationBolouri, H., Farrar, J. E., Triche, T., Ries, R. E., Lim, E. L., Alonzo, T. A., Ma, Y., Moore, R., Mungall, A. J., Marra, M. A., et al. (2018) · Nature Medicine · doi:10.1038/nm.4439 · Cited by 848
RNA N6-methyladenosine modification in cancers: current status and perspectives
Deng, X., Su, R., Weng, H., Huang, H., Li, Z., & Chen, J. (2018) · Cell Research · doi:10.1038/s41422-018-0034-6 · Cited by 845
Self-citationThe Wnt/β-Catenin Pathway Is Required for the Development of Leukemia Stem Cells in AML
Wang, Y., Krivtsov, A. V., Sinha, A. U., North, T. E., Goessling, W., Feng, Z., Zon, L. I., & Armstrong, S. A. (2010) · Science · doi:10.1126/science.1186624 · Cited by 763
Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia
Somervaille, T. C. P., & Cleary, M. L. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.020 · Cited by 582
m6A modulates haematopoietic stem and progenitor cell specification
Zhang, C., Chen, Y., Sun, B., Wang, L., Yang, Y., Ma, D., Lv, J., Heng, J., Ding, Y., Xue, Y., et al. (2017) · Nature · doi:10.1038/nature23883 · Cited by 582
Self-citationParis, J., Morgan, M., Campos, J., Spencer, G. J., Shmakova, A., Ivanova, I., Mapperley, C., Lawson, H., Wotherspoon, D. A., Sepulveda, C., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.03.021 · Cited by 502
Biology and relevance of human acute myeloid leukemia stem cells
Thomas, D., & Majeti, R. (2017) · Blood · doi:10.1182/blood-2016-10-696054 · Cited by 500
Distinct microRNA expression profiles in acute myeloid leukemia with common translocations
Li, Z., Lu, J., Sun, M., Mi, S., Zhang, H., Luo, R. T., Chen, P., Wang, Y., Yan, M., Qian, Z., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808266105 · Cited by 457
Self-citationMeng, J., Lu, Z., Liu, H., Zhang, L., Zhang, S., Chen, Y., Rao, M. K., & Huang, Y. (2014) · Methods · doi:10.1016/j.ymeth.2014.06.008 · Cited by 375
Self-citationZhang, J., Guo, S., Piao, H.-Y., Wang, Y., Wu, Y., Meng, X.-Y., Yang, D., Zheng, Z.-C., & Zhao, Y. (2019) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-019-00690-8 · Cited by 302
Yan, M., Kanbe, E., Peterson, L. F., Boyapati, A., Miao, Y., Wang, Y., Chen, I.-M., Chen, Z., Rowley, J. D., Willman, C. L., et al. (2006) · Nature Medicine · doi:10.1038/nm1443 · Cited by 279
Suppression of m6A reader Ythdf2 promotes hematopoietic stem cell expansion
Li, Z., Qian, P., Shao, W., Shi, H., He, X. C., Gogol, M., Yu, Z., Wang, Y., Qi, M., Zhu, Y., et al. (2018) · Cell Research · doi:10.1038/s41422-018-0072-0 · Cited by 257
Self-citationChapter 17 Messenger RNA Half‐Life Measurements in Mammalian Cells
Chen, C. A., Ezzeddine, N., & Shyu, A. (2008) · Methods in Enzymology · doi:10.1016/s0076-6879(08)02617-7 · Cited by 256
Self-citationWTAP is a novel oncogenic protein in acute myeloid leukemia
Bansal, H., Yihua, Q., Iyer, S. P., Ganapathy, S., Proia, D., Penalva, L. O., Uren, P. J., Suresh, U., Carew, J. S., Karnad, A. B., et al. (2014) · Leukemia · doi:10.1038/leu.2014.16 · Cited by 243
Wang, J., Li, Y., Wang, P., Han, G., Zhang, T., Chang, J., Yin, R., Shan, Y., Wen, J., Xie, X., et al. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.04.001 · Cited by 243
TET1 plays an essential oncogenic role in MLL -rearranged leukemia
Huang, H., Jiang, X., Li, Z., Li, Y., Song, C.-X., He, C., Sun, M., Chen, P., Gurbuxani, S., Wang, J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310656110 · Cited by 220
Self-citationGenetic alterations of m6A regulators predict poorer survival in acute myeloid leukemia
Kwok, C.-T., Marshall, A. D., Rasko, J. E. J., & Wong, J. J. L. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0410-6 · Cited by 199
Polysome Fractionation and Analysis of Mammalian Translatomes on a Genome-wide Scale
Gandin, V., Sikström, K., Alain, T., Morita, M., McLaughlan, S., Larsson, O., & Topisirovic, I. (2014) · Journal of Visualized Experiments · doi:10.3791/51455 · Cited by 198
Blockade of miR-150 Maturation by MLL-Fusion/MYC/LIN-28 Is Required for MLL-Associated Leukemia
Jiang, X., Huang, H., Li, Z., Li, Y., Wang, X., Gurbuxani, S., Chen, P., He, C., You, D., Zhang, S., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.028 · Cited by 171
Self-citationLi, Z., Huang, H., Chen, P., He, M., Li, Y., Arnovitz, S., Jiang, X., He, C., Hyjek, E., Zhang, J., et al. (2012) · Nature Communications · doi:10.1038/ncomms1681 · Cited by 164
Self-citationLi, Z., Huang, H., Li, Y., Jiang, X., Chen, P., Arnovitz, S., Radmacher, M. D., Maharry, K., Elkahloun, A., Yang, X., et al. (2012) · Blood · doi:10.1182/blood-2011-10-386235 · Cited by 160
Self-citationThalhammer, A., Bencokova, Z., Poole, R., Loenarz, C., Adam, J., O′Flaherty, L., Schödel, J., Mole, D. R., Giaslakiotis, K., Schofield, C. J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016210 · Cited by 155
PBX3 is an important cofactor of HOXA9 in leukemogenesis
Li, Z., Zhang, Z., Li, Y., Arnovitz, S., Chen, P., Huang, H., Jiang, X., Hong, G.-M., Kunjamma, R. B., Ren, H., et al. (2012) · Blood · doi:10.1182/blood-2012-07-442004 · Cited by 154
Self-citationRight on target: eradicating leukemic stem cells
Krause, D. S., & Etten, R. A. V. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.09.003 · Cited by 150
Wang, H., Zuo, H., Liu, J., Wen, F., Gao, Y., Zhu, X., Liu, B., Xiao, F., Wang, W., Huang, G., et al. (2018) · Cell Research · doi:10.1038/s41422-018-0082-y · Cited by 137
Piekorz, R. P., Hoffmeyer, A., Duntsch, C. D., McKay, C., Nakajima, H., Sexl, V., Snyder, L., Rehg, J. E., & Ihle, J. N. (2002) · The EMBO Journal · doi:10.1093/emboj/21.4.653 · Cited by 125
AML cells are differentially sensitive to chemotherapy treatment in a human xenograft model
Wunderlich, M., Mizukawa, B. E., Chou, F., Sexton, C., Shrestha, M., Saunthararajah, Y., & Mulloy, J. C. (2013) · Blood · doi:10.1182/blood-2012-10-464677 · Cited by 124
Mettl3–Mettl14 methyltransferase complex regulates the quiescence of adult hematopoietic stem cells
Yao, Q. J., Sang, L., Lin, M., Yin, X., Dong, W., Gong, Y., & Zhou, B. O. (2018) · Cell Research · doi:10.1038/s41422-018-0062-2 · Cited by 114
RNA Modifications in Cancer: Functions, Mechanisms, and Therapeutic Implications
Huang, H., Weng, H., Deng, X., & Chen, J. (2019) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030419-033357 · Cited by 96
Self-citationTargeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia
Jiang, X., Hu, C., Ferchen, K., Nie, J., Cui, X., Chen, C., Cheng, L., Zuo, Z., Seibel, W. L., He, C., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-02290-w · Cited by 89
Self-citationJung, C. K., Jung, J. H., Park, G. S., Lee, A., Kang, C. S., & Lee, K. Y. (2006) · Pathology International · doi:10.1111/j.1440-1827.2006.01998.x · Cited by 71
Polysome Fractionation and Analysis of Mammalian Translatomes on a Genome-wide Scale
Gandin, V., Sikström, K., Alain, T., Morita, M., McLaughlan, S., Larsson, O. S., & Topisirović, I. (2014) · Journal of Visualized Experiments · doi:10.3791/51455-v · Cited by 56
RNA N 6-Methyladenosine Modification in Normal and Malignant Hematopoiesis
Weng, H., Huang, H., & Chen, J. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-7342-8_4 · Cited by 53
Self-citationCho, S. H., Ha, M., Cho, Y. H., Ryu, J. H., Yang, K., Lee, K. H., Han, M., Oh, S., & Kim, Y. H. (2018) · Annals of Hepato-Biliary-Pancreatic Surgery · doi:10.14701/ahbps.2018.22.4.305 · Cited by 49
TACC3 promotes stemness and is a potential therapeutic target in hepatocellular carcinoma
Zhou, D.-S., Wang, H., Zhou, Z., Zhang, Y., Zhong, Q., Xu, L., Huang, Y., Yeung, S. J., Chen, M.-S., & Zeng, M. (2015) · Oncotarget · doi:10.18632/oncotarget.4643 · Cited by 48
Disruption of Tacc3 function leads to in vivo tumor regression
Yao, R., Natsume, Y., Saiki, Y., Shioya, H., Takeuchi, K., Yamori, T., Toki, H., Aoki, I., Saga, T., & Noda, T. (2011) · Oncogene · doi:10.1038/onc.2011.235 · Cited by 40
Schneider, L. X., Eßmann, F., Kletke, A., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210628 · Cited by 40
Wang, Y., Ding, X., Hu, H., He, Y. M., Lu, Z., Wu, P., Tian, L., Xia, T., Yin, J., Yuan, H., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31657 · Cited by 39
Overexpression of TACC3 in Breast Cancer Associates With Poor Prognosis
Song, H., Liu, C., Shen, N., Yi, P., Fang, D., Li, X., Zhang, N., & Huang, T. (2016) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000392 · Cited by 37
Suhail, T. V., Singh, P., & Manna, T. K. (2015) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2014.12.001 · Cited by 33
A Transgenic Core Facility’s Experience in Genome Editing Revolution
Yuan, C. L., & Hu, Y. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-63904-8_4 · Cited by 29
Self-citationDrug developers delve into the cell's trash-disposal machinery
Chi, K. R. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.86 · Cited by 14
Sun, Y., Tian, Y., Wang, G., Zhao, S., Han, B. R., Li, Y., & Jiang, C. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030235 · Cited by 12
Hodge, R. (1998) · Humana Press eBooks · doi:10.1385/0-89603-494-1:73 · Cited by 5
Cited by
The role of m6A modification in the biological functions and diseases
Jiang, X., Liu, B., Nie, Z., Duan, L., Xiong, Q., Jin, Z., Yang, C., & Chen, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00450-x · Cited by 2,335
Self-citationThe role of m6A, m5C and Ψ RNA modifications in cancer: Novel therapeutic opportunities
Nombela, P., Miguel-López, B., & Blanco, S. (2021) · Molecular Cancer · doi:10.1186/s12943-020-01263-w · Cited by 492
m6A modification: recent advances, anticancer targeted drug discovery and beyond
Deng, L.-J., Deng, W.-Q., Fan, S.-R., Chen, M.-F., Qi, M., Lyu, W.-Y., Qi, Q., Tiwari, A. K., Chen, J.-X., Zhang, D.-M., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01510-2 · Cited by 366
Self-citationThe roles and implications of RNA m6A modification in cancer
Deng, X., Qing, Y., Horne, D., Huang, H., & Chen, J. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00774-x · Cited by 364
Self-citationTumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance
Liu, Y., Liang, G., Xu, H., Dong, W., Dong, Z., Qiu, Z., Zhang, Z., Li, F., Huang, Y., Li, Y., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.04.001 · Cited by 361
Metadata
- Authors
- Shen, C., Sheng, Y., Zhu, A. C., Robinson, S., Jiang, X., Dong, L., Chen, H., Su, R., Yin, Z., Li, W., Deng, X., Chen, Y., Hu, Y.-C., Weng, H., Huang, H., Prince, E., Cogle, C. R., Sun, M., Zhang, B., Chen, C.-W., Marcucci, G., He, C., Qian, Z., & Chen, J.
- Venue
- Cell Stem Cell
- Publisher
- Elsevier BV
- Published
- 2020-07
- Volume
- 27
- Issue
- 1
- Pages
- 64-80.e9
- ISSN
- 1875-9777 (ISSN-L)
- 1934-5909
- OpenAlex
- W3026033619
- Cited by
- 373
- References
- 79
- FWCI
- 16.25
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.